Interaction Color Code
Clinical Bottom Line
Do not coadminister: potientially reduced levels of velpatasvir and voxilaprevir
Drug 1
Drug 1 effect
Not studied
Drug 2 effect
Not studied (may decrease velpatasvir and voxilaprevirlevels)
Clinical Effects
Potential loss of anti-HCV efficacy
Management
Contraindicated. Use alternative agents.
Import ID
551
